Company: SMNR
Filing Date: 2025-08-12
Form Type: S-4/A
Source: 0001193125-25-178821
Chunk: 811

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-08-12
Form: S-4/A
Chunk 811
---
 preference shares issued and outstanding. Class A Ordinary Shares –The Company is authorized to issue 200,000,000Class A ordinary shares with a par value of $ 0.0001per share. As of March 31, 2025 and December 31, 2024, there were 510,000Class A ordinary shares issued and outstanding, excluding 751,837Class A ordinary shares subject to possible redemption, respectively. Class B Ordinary Shares –The Company is authorized to issue 20,000,000Class B ordinary shares with a par value of $ 0.0001per share. As of March 31, 2025 and December 31, 2024, there were 2,062,500Class B ordinary shares issued and outstanding. On May 23, 2022, 93,750Class B ordinary shares were forfeited as the underwriters did not exercise the over-allotment option on the remaining 375,000Public Units. Prior to the Company’s initial Business Combination, only holders of Class B ordinary shares will have the right to vote on the appointment of directors and holders of a majority of the Company’s Class B ordinary shares may remove a member of the board of directors for any reason. In addition, in a vote to continue the Company in a jurisdiction outside the Cayman Islands (which requires the approval of at least two-thirdsof the votes of all ordinary shares voted at a general meeting), holders of founder shares will have ten votes for every founder share and holders of Class A ordinary shares will have one vote for every Class A ordinary share and, as a result, the Company’s initial shareholders will be able to approve any such proposal without the vote of any other shareholder. The Class B ordinary shares will automatically convert into Class A ordinary shares on the consummation of the initial Business Combination at a ratio such that the number of Class A ordinary shares issuable upon conversion of all founder shares will equal, in the aggregate, on an as-convertedbasis, approximately 20% of the sum of (i) the total number of ordinary shares issued and outstanding upon completion of the IPO, plus (ii) the total number of Class A ordinary shares issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination (after giving effect to any redemptions of Class A ordinary shares by Public Shareholders), excluding any Class A